Avandia win a Pyrrhic victory for consumers
June 14, 2013 at 06:30 AM EDT
The Type 2 diabetes drug Avandia was essentially taken off the market by the FDA for several years because of a study that said it was dangerous. It’s now back, but the lesson learned here may not be the correct one.